Showing 1 - 6 results of 6 for search 'Margherita Curlo', query time: 0.04s Refine Results
  1. 1
    Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic

    Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic by Mauro Mastronardi, Margherita Curlo, Maurizio Polignano, Natalino Vena, Daniela Rossi, Gianluigi Giannelli

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review

    Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report... by Mauro Mastronardi, Elisabetta Cavalcanti, Nunzia Labarile, Raffaele Armentano, Francesco Gabriele, Margherita Curlo

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Effects of Different Biological Therapies on S1/S2 Antibody Response to SARS-CoV-2 Vaccination in a Cohort of Patients with Inflammatory Bowel Disease

    Effects of Different Biological Therapies on S1/S2 Antibody Response to SARS-CoV-2 Vaccination in a Cohort of Patients with Inflammatory Bowel Disease by Nunzia Labarile, Fabio Castellana, Annamaria Sila, Pasqua Letizia Pesole, Sergio Coletta, Margherita Curlo, Rodolfo Sardone, Gianluigi Giannelli, Mauro Mastronardi

    Published 2022-07-01
    Get full text
    Article
  4. 4
    Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

    Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis by Roberta Zupo, Annamaria Sila, Fabio Castellana, Roberto Bringiotti, Margherita Curlo, Giovanni De Pergola, Sara De Nucci, Gianluigi Giannelli, Mauro Mastronardi, Rodolfo Sardone

    Published 2022-09-01
    Get full text
    Article
  5. 5
    Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease

    Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease by Mauro Mastronardi, Margherita Curlo, Elisabetta Cavalcanti, Osvaldo Burattini, Renato Cuppone, Romina Tauro, Stefania De Santis, Stefania De Santis, Grazia Serino, Pasqua Letizia Pesole, Elisa Stasi, Maria Lucia Caruso, Rossella Donghia, Vito Guerra, Pietro Giorgio, Marcello Chieppa

    Published 2019-11-01
    Get full text
    Article
  6. 6
    Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study

    Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study by Marina Liso, Annamaria Sila, Giulio Verna, Aurelia Scarano, Rossella Donghia, Fabio Castellana, Elisabetta Cavalcanti, Pasqua Letizia Pesole, Eduardo Maria Sommella, Antonio Lippolis, Raffaele Armentano, Anna Maria Giudetti, Daniele Vergara, Pietro Campiglia, Rodolfo Sardone, Margherita Curlo, Mauro Mastronardi, Katia Petroni, Chiara Tonelli, Angelo Santino, Marcello Chieppa

    Published 2022-01-01
    Get full text
    Article

Search Tools: